Shalom Life | April 24, 2014

EXCLUSIVE: Should MDMA be Legalized for Medicinal Purposes?

Shalom Life speaks to Mimi Peleg, a clinical research assistant at the Multidisciplinary Association for Psychedelic Studies, on the effects MDMA has in battling Post-Traumatic Stress Disorder

By: Gideon Greenbaum-Shinder

Published: October 21st, 2013 in Health » Israel

EXCLUSIVE: Should MDMA be Legalized for Medicinal Purposes?

When someone mentions psychedelic drugs or MDMA, the immediate response is to think about ecstatic smiling teenagers waving glow sticks at a nightclub, dancing vigorously at an after-hours club to some hard-hitting, bass-laden electronic music.

One may wonder: where do these stereotypes come from? Surely pop-culture contributes to our stereotypical overview of these illegal compounds. The infamous Trinidad James lyric, "popped a molly I’m sweating," or Madonna’s "how many of you have seen Molly?" comment, surely hasn’t helped either.

Meanwhile, our thoughts tend to be more sympathetic and medically based when concerning a cancer patient taking prescription painkillers or a mentally ill person taking anti-depressants.

The Multidisciplinary Association for Psychedelic Studies (MAPS) is trying to change and improve this image and legitimately prove the many positive effect of various psychedelic compounds. "We are studying whether MDMA-assisted psychotherapy has the potential to heal the psychological and emotional damage caused by sexual assault, war, violent crime, and other traumas," reads their website.


Founded in 1986 by Rick Doblin, Ph.D., MAPS is a non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.

Shalom Life had a chance to speak to Ohio native Mimi Peleg, who serves as a clinical research assistant for MAPS, about their ongoing research.

Particularly, we asked the Te Aviv resident, and Director of Large Scale Cannabis Training for Mechkar, Israel's federal government-approved medical marijuana distribution centre (which she helped create and develop after making aliyah), about monitoring the clinical trial that studies the effect of MDMA-assisted therapy on Post-Traumatic Stress Disorder (PTSD).

"Scientists have come to view psychedelics as the most powerful tool we possess in treating PTSD, radically changing the old picture of the drug," Peleg writes in an article published by Greenbridge Medical Services.

According to The Israel Center for the Treatment of Psychotrauma (ICTP), she writes, an estimated 9% of Israelis suffer from PTSD. "While this is in the mid-range of PTSD rates in areas near Israel, it is three times the rate of PTSD in the U.S. and other Western countries. Israel’s high rate could be due to the many wars, presence of first and second generation Holocaust Survivors, and numerous other factors."

Supervising and monitoring protocol, Peleg ensures that all factors are up to code in the testing process. Working with drugs that are often seen as unorthodox in the general community, I ask her what is it like to work under such scrutiny.

"I like it," Peleg replies casually. "We want to improve ourselves, we know the world is looking for new ways and we want the worlds help. People will soon realize that our work didn’t cause a [negative] revolution, other than a revolution of health."

She adds that MAPS is simply hoping for psychologists to be able to use MDMA as a controlled tool, rather than looking to legalize it and hold late-night dance parties. "MAPS envisions a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits."

Methylenedioxymethamphetamine, better known as MDMA, was initially developed in 1912 by Anton Köllisch, a scientist at the German chemical and pharmaceutical company Merck, while investigating ways to stop abnormal bleeding. In the 1970s, several psychiatrists used the chemical to augment communication with their patients. This practice ended quickly when MDMA became better known as a street drug; the compound was prohibited in the US in 1985.


(Mimi Peleg)

Certain taboo's and predisposed forms of judgement tend to keep support tentative for this organization in the mainstream; however MAPS is slowly making headway. "The people that were destined to donate to psychedelic research are doing so, the taboo is actually being turned around all the time especially now that this research has been featured in NY Times, ABC News, BBC News and many more," Peleg says.

She also accredits founder Rick Doblin for these perceptual advances as well as their current funding. "MAPS actually got a 5 million dollar donation last year," she tells me. The organization is currently conducting studies of MDMA and psychotherapy in five clinical trials around the world: Switzerland, Australia, the UK, Canada, and the U.S.

MDMA is commonly heralded by the reputation of it’s impure cousin, a street form called 'ecstasy'. MAPS now has a growing statistical base to disprove common opinion that all illegal substances are simple poison pills to be avoided. In fact, Peleg says that "over 600 people have been treated for PTSD with MDMA treatment based therapy with an 86% success rate," far outstripping conventional methods of treatment.

The organization is currently "undertaking a 10 year, $15 million plan to make MDMA into an FDA-approved prescription medicine, and is currently the only organization in the world funding clinical trials of MDMA-assisted psychotherapy." They also make every effort to recruit Israeli combat soldiers with PTSD.

Israeli Comedian on 4.20: Let My People Smoke! [VIDEO] Israeli Comedian on 4.20: Let My People Smoke! [VIDEO] TrendingEmotional Pain Isn't Just in Your Head Emotional Pain Isn't Just in Your Head TrendingIsraeli Researcher Makes Significant Brain Cancer Discovery Israeli Researcher Makes Significant Brain Cancer Discovery Trending
 

Jewish Hall of Fame: Émile Durkheim

April 23, 2014 | By Zak Edwards
Jewish Hall of Fame: Émile Durkheim

The French sociologist, social psychologist and philosopher is considered to be one of the founding fathers of social science

Read More

Anton Yelchin and Zooey Deschanel Slated for ‘The Driftless Area’

April 23, 2014 | By Sarah Bauder
Anton Yelchin and Zooey Deschanel Slated for ‘The Driftless Area’

The film will also star John Hawkes, Ciaran Hinds, and Alia Shawkat.

Read More

Sarah Silverman Apologizes in Advance For Swastika Doodle

April 23, 2014 | By Ashley Baylen
Sarah Silverman Apologizes in Advance For Swastika Doodle

The controversial comedian posted a doodle she drew of a swastika to her Twitter feed.

Read More

Andy Samberg to Return to ‘SNL’ as Host

April 23, 2014 | By Ashley Baylen
Andy Samberg to Return to ‘SNL’ as Host

The 'Saturday Night Live' alum will be hosting on May 17th.

Read More

Drake Lint Rolls His Pants During Raptors Playoff Game [VIDEO]

April 23, 2014 | By Ashley Baylen
Drake Lint Rolls His Pants During Raptors Playoff Game [VIDEO]

The Raptors global brand ambassador wanted to ensure he looked his best while his team beat the Brooklyn Nets

Read More

Drew Barrymore and Will Kopelman Welcome Baby Frankie

April 23, 2014 | By Ashley Baylen
Drew Barrymore and Will Kopelman Welcome Baby Frankie

The actress announced the birth of another happy baby girl on Tuesday.

Read More

Mel Brooks to Star in Autobiographical One-Man Show

April 23, 2014 | By Ashley Baylen
Mel Brooks to Star in Autobiographical One-Man Show

The 87-year old actor/director is planning a solo show in Los Angeles for one-night only.

Read More

Travel Back in Time with Google Street View

April 23, 2014 | By Daniel Koren
Travel Back in Time with Google Street View

Google's latest feature allows you to scroll through past Street view photos, whether in New York, Toronto, or Singapore

Read More

More Headlines